Kevin S Oh
Overview
Explore the profile of Kevin S Oh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
1116
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee G, Aitelli A, Niemierko A, Lamba N, Kim D, Curry W, et al.
Adv Radiat Oncol
. 2025 Mar;
10(3):101726.
PMID: 40034477
Purpose: While adjuvant radiation therapy (RT) may prolong progression-free survival in resected atypical meningiomas, whether such progression-free survival benefit outweighs potential treatment toxicities remains controversial. Here, we compare the acute...
2.
Fenn B, Karhade A, Groot O, Collins A, Balboni T, Oh K, et al.
Clin Spine Surg
. 2024 Feb;
37(7):E290-E296.
PMID: 38321614
Summary Of Background Data: The SORG-ML algorithms for survival in spinal metastatic disease were developed in patients who underwent surgery and were externally validated for patients managed operatively. Objective: To...
3.
Tsien C, Pugh S, Dicker A, Raizer J, Matuszak M, Lallana E, et al.
J Clin Oncol
. 2022 Oct;
41(6):1285-1295.
PMID: 36260832
Purpose: To assess whether reirradiation (re-RT) and concurrent bevacizumab (BEV) improve overall survival (OS) and/or progression-free survival (PFS), compared with BEV alone in recurrent glioblastoma (GBM). The primary objective was...
4.
Saraf A, Yock T, Niemierko A, Oh K, Curry W, Butler W, et al.
Neuro Oncol
. 2022 Jun;
24(12):2180-2189.
PMID: 35671386
Background: Medulloblastoma (MB) is a rare central nervous system malignancy of adults, with limited contemporary studies to define treatment guidelines and expected late toxicity. Methods: A single-center, retrospective study was...
5.
Lee G, Lamba N, Niemierko A, Kim D, Chapman P, Loeffler J, et al.
Int J Radiat Oncol Biol Phys
. 2020 Aug;
109(1):252-266.
PMID: 32777336
Purpose: The optimal timing of adjuvant radiation therapy (RT) in the management of atypical meningiomas remains controversial. We compared the outcomes of atypical meningiomas managed with upfront adjuvant RT versus...
6.
Lebow E, Hwang W, Zieminski S, Wang Y, Niemierko A, Mehan Jr W, et al.
J Neurooncol
. 2020 Apr;
148(1):81-88.
PMID: 32307637
Purpose: Cranial irradiation results in cognitive decline, which is hypothesized to be partially attributable to hippocampal injury and stem cell loss. Recent advances allow for targeted reduction of radiation dose...
7.
Byrne J, Botticello T, Niemierko A, Shih H, Loeffler J, Oh K
Sci Rep
. 2020 Apr;
10(1):6331.
PMID: 32286375
The paradigm for post-operative cavity radiation therapy has shifted to more targeted, less morbid approaches. Single-fraction or hypofractionated radiation therapy is a common approach to treating the postoperative cavity but...
8.
McDuff S, Dietrich J, Atkins K, Oh K, Loeffler J, Shih H
Cancer Med
. 2019 Nov;
9(1):3-11.
PMID: 31701682
Purpose: The majority of patients with high-risk lower grade gliomas (LGG) are treated with single-agent temozolomide (TMZ) and radiotherapy despite three randomized trials showing a striking overall survival benefit with...
9.
Lamba N, Hwang W, Kim D, Niemierko A, Marciscano A, Mehan Jr W, et al.
World Neurosurg
. 2019 Oct;
133:e804-e812.
PMID: 31605839
Background: Histopathological grading of meningiomas is insufficient for optimal risk stratification. The purpose of the present study was to determine the prognostic value of atypical histopathological features across all nonmalignant...
10.
Niyazi M, Niemierko A, Paganetti H, Sohn M, Schapira E, Goldberg S, et al.
Radiother Oncol
. 2019 Sep;
142:154-161.
PMID: 31563411
Background And Purpose: High-dose fractionated radiotherapy is often necessary to achieve long-term tumor control in several types of tumors involving or within close proximity to the brain. There is limited...